Argidene

N/A

Report date: 2022/12/24 20:00:29
NME

Base Information

Drug NameArgidene
Drug Alias NameRGD peptide matrix gel - Telios PharmaceuticalsArginine-glycine-aspartic acid peptide matrix gelArgidene GelTelio-Derm Gel
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsDiabetic FootPeriodontitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEgypt
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTelios Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesMinia University
Inactive CompaniesTelios Pharmaceuticals
Active IndicationsPeriodontitis
Inactive IndicationsDiabetic Foot

Other Information

ATC CodeN/A
Related LinksN/A